A detailed history of Tower Research Capital LLC (Trc) transactions in Moderna, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 72,093 shares of MRNA stock, worth $4.74 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
72,093
Previous 28,330 154.48%
Holding current value
$4.74 Million
Previous $3.02 Million 183.66%
% of portfolio
0.15%
Previous 0.07%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$101.21 - $166.61 $4.43 Million - $7.29 Million
43,763 Added 154.48%
72,093 $8.56 Million
Q1 2024

May 15, 2024

SELL
$85.37 - $115.44 $2.62 Million - $3.54 Million
-30,636 Reduced 51.96%
28,330 $3.02 Million
Q4 2023

Feb 13, 2024

BUY
$69.51 - $104.43 $2.65 Million - $3.98 Million
38,132 Added 183.03%
58,966 $5.86 Million
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $116,656 - $153,198
1,210 Added 6.17%
20,834 $2.15 Million
Q2 2023

Aug 14, 2023

BUY
$118.5 - $160.53 $1.5 Million - $2.03 Million
12,633 Added 180.7%
19,624 $2.38 Million
Q1 2023

May 09, 2023

SELL
$135.66 - $197.02 $609,656 - $885,407
-4,494 Reduced 39.13%
6,991 $1.07 Million
Q4 2022

Feb 10, 2023

SELL
$118.38 - $210.04 $7.93 Million - $14.1 Million
-66,984 Reduced 85.36%
11,485 $2.06 Million
Q3 2022

Nov 10, 2022

BUY
$118.07 - $194.18 $2.33 Million - $3.84 Million
19,772 Added 33.68%
78,469 $9.28 Million
Q2 2022

Aug 15, 2022

SELL
$117.13 - $176.59 $6.51 Million - $9.81 Million
-55,552 Reduced 48.62%
58,697 $8.39 Million
Q1 2022

May 12, 2022

BUY
$126.46 - $235.05 $9.04 Million - $16.8 Million
71,508 Added 167.31%
114,249 $19.7 Million
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $4.77 Million - $7.78 Million
21,125 Added 97.73%
42,741 $10.9 Million
Q3 2021

Nov 15, 2021

SELL
$221.9 - $484.47 $6.27 Million - $13.7 Million
-28,240 Reduced 56.64%
21,616 $8.32 Million
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $3.36 Million - $6.09 Million
25,898 Added 108.1%
49,856 $11.7 Million
Q1 2021

May 17, 2021

BUY
$109.18 - $185.98 $1.96 Million - $3.34 Million
17,979 Added 300.7%
23,958 $3.14 Million
Q4 2020

Feb 16, 2021

SELL
$65.74 - $169.86 $342,045 - $883,781
-5,203 Reduced 46.53%
5,979 $624,000
Q3 2020

Nov 16, 2020

BUY
$54.34 - $94.85 $542,802 - $947,456
9,989 Added 837.3%
11,182 $791,000
Q2 2020

Aug 13, 2020

BUY
$29.67 - $80.0 $35,396 - $95,440
1,193 New
1,193 $77,000
Q1 2020

May 15, 2020

SELL
$17.78 - $31.58 $178,102 - $316,336
-10,017 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$13.93 - $21.28 $76,489 - $116,848
5,491 Added 121.32%
10,017 $196,000
Q3 2019

Nov 05, 2019

BUY
$12.26 - $18.07 $55,488 - $81,784
4,526 New
4,526 $72,000
Q2 2019

Aug 13, 2019

SELL
$13.7 - $28.34 $50,813 - $105,113
-3,709 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$14.45 - $23.7 $53,595 - $87,903
3,709 New
3,709 $75,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.